Literature DB >> 3290700

A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration.

N E Anderson1, C Budde-Steffen, R G Wiley, L Thurman, M K Rosenblum, S E Nadeau, J B Posner.   

Abstract

An anti-Purkinje cell antibody was found in the serum and CSF of a man with adenocarcinoma of the lung and paraneoplastic cerebellar degeneration (PCD). This antibody differed from the autoantibodies found in patients with gynecologic cancer and PCD in that it produced a different pattern of Purkinje cell cytoplasmic staining, did not react with PCD antigens in Purkinje cell Western blots, and the antigen had a different species distribution. Unlike the antinuclear antibody found in patients with PCD and small-cell lung carcinoma, the antigen was restricted to the cytoplasm of Purkinje cells. If autoantibodies are important in the pathogenesis of PCD, this case illustrates that they can recognize different antigenic epitopes in the nervous system, but cause similar clinicopathologic syndromes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3290700     DOI: 10.1212/wnl.38.7.1018

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

Review 1.  A review of the therapy of paraneoplastic neurologic syndromes.

Authors:  A Das; F H Hochberg; S McNelis
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Pursuing an occult carcinoma in a patient with subacute cerebellar degeneration and anticerebellar antibodies. Need for vigorous follow-up.

Authors:  J E Greenlee; H R Brashear; K A Jaeckle; A Geleris; K Jordan
Journal:  West J Med       Date:  1992-02

3.  Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer.

Authors:  L Sabater; L Bataller; A F Carpentier; M L Aguirre-Cruz; A Saiz; B Benyahia; J Dalmau; F Graus
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06-26       Impact factor: 10.154

4.  Paraneoplastic cerebellar degeneration associated with multiple myeloma--3.4 years follow up.

Authors:  S Akpinar; O Berk; L Karaca
Journal:  J Neurooncol       Date:  1990-08       Impact factor: 4.130

5.  Limbic encephalitis occurring in association with Alzheimer's disease.

Authors:  R C Sutton; M H Lipper; H R Brashear
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-07       Impact factor: 10.154

6.  Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes.

Authors:  J Honnorat; J C Antoine; E Derrington; M Aguera; M F Belin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-09       Impact factor: 10.154

7.  Paraneoplastic cerebellar degeneration and limbic encephalitis in a patient with adenocarcinoma of the colon.

Authors:  T Tsukamoto; R Mochizuki; H Mochizuki; M Noguchi; H Kayama; M Hiwatashi; T Yamamoto
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

Review 8.  'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

Review 9.  Inositol 1,4,5-trisphosphate receptor type 1 autoantibody (ITPR1-IgG/anti-Sj)-associated autoimmune cerebellar ataxia, encephalitis and peripheral neuropathy: review of the literature.

Authors:  Brigitte Wildemann; Christian Roth; Sven Jarius; Stefan Bräuninger; Ha-Yeun Chung; Christian Geis; Jürgen Haas; Lars Komorowski
Journal:  J Neuroinflammation       Date:  2022-07-30       Impact factor: 9.587

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.